Furosemide CRI
Refractory congestive heart failure (MMVD stage D, end-stage DCM, refractory pulmonary edema), acute fulminant pulmonary edema unresponsive to bolus diuretic therapy, oliguric or anuric acute kidney injury (in select protocols, with appropriate volume status), and volume management in life-threatening hyperkalemia. CRI delivery is preferred over repeated bolus for severe or refractory cases: smoother diuresis, less ototoxicity, better natriuretic efficiency. Continuous monitoring required: serum electrolytes, creatinine/BUN, body weight, urine output, blood pressure.
How this calculator works
Enter the patient's weight and the desired CRI dose. The calculator picks a concentration (5, 2, or 1 mg/mL) that keeps the pump in its accurate range.
Cat doses run lower than dogs (0.25–1 vs 0.25–2 mg/kg/hr), and the cat-specific caution threshold is correspondingly lower; cats are more prone to dehydration and electrolyte derangements at any given diuretic dose.
Loading dose (1–4 mg/kg IV over 1–2 minutes) is shown above the CRI maintenance rate. Drive the initial diuresis with the loading bolus; the CRI maintains response with a smoother curve and less ototoxicity than repeated bolus dosing.
Enter a patient weight to see the result.
How the calculation works
Furosemide CRI is dosed in mg/kg/hr. Because the prepared CRI concentration is expressed in µg/mL, the formula needs a × 1000 to convert the mg dose into µg before dividing:
Patient weight (kg) times dose (mg per kg per hour) gives mg per hour. Multiplying by 1,000 converts mg to µg so the units match the bag concentration. Dividing by µg/mL yields mL per hour.
Worked example with current inputs
Enter a patient weight to see the worked example.
Recommended dilutions
| Target concentration | Dilution | When useful |
|---|---|---|
| 5000 µg/mL | 5 mL of 50 mg/mL stock (250 mg total) into 45 mL of 0.9% NaCl in a 50 mL syringe (final volume 50 mL) | Recommended for patients ≥15 kg. Concentrated end of the range, minimizes carrier-fluid load in volume-restricted patients with CHF. |
| 2000 µg/mL | 2 mL of 50 mg/mL stock (100 mg total) into 48 mL of 0.9% NaCl in a 50 mL syringe (final volume 50 mL) | Standard preparation for patients 5–15 kg. Matches the most common ICU CHF workflow. |
| 1000 µg/mL | 1 mL of 50 mg/mL stock (50 mg total) into 49 mL of 0.9% NaCl in a 50 mL syringe (final volume 50 mL) | Dilute preparation for patients <5 kg (cats and small dogs). Essential when more concentrated preps would drop pump rate below 2 mL/hr at conservative cat doses. |
Stock: 50 mg/mL injectable, 50 mL multi-dose vial (2 500 mg per vial). For CRI: 0.9% NaCl is the preferred diluent. 5% dextrose is borderline; some references list mild incompatibility; if D5W must be used, prepare fresh and deliver promptly. Furosemide is sensitive to acidic conditions; precipitates in lactated Ringer's and most acidic IV fluids. Avoid mixing in the same line with calcium-containing solutions, epinephrine, or any acidic drug. Light-protection: not strictly required for short-term infusions, but discard the prepared syringe if any color change to yellow or amber appears; furosemide degrades in ambient light over hours, particularly when exposed at elevated temperature. Companion medications: pair the CRI with electrolyte monitoring at 4–6 hour intervals. Hypokalemia frequently develops within the first 12 hours and is best managed preemptively with potassium-containing IV fluid or potassium supplementation rather than waiting for severe derangement.
Dilution helper — Furosemide CRI
Work out how many mL of stock drug and diluent to combine for any target concentration. Stock is pre-filled for Furosemide CRI; change it if you're using a different vial.
Enter stock, target concentration, and final volume.